SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 53 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $2,000 | – | 193 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PARSONS CAPITAL MANAGEMENT INC/RI | 195,165 | $1,559,000 | 0.21% |
DAFNA Capital Management LLC | 27,412 | $219,000 | 0.19% |
Verity & Verity, LLC | 12,385 | $99,000 | 0.03% |
Baker Brothers Advisors | 219,298 | $1,752,000 | 0.02% |
Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 97,286 | $777,000 | 0.01% |
BRYN MAWR TRUST Co | 14,000 | $112,000 | 0.01% |
BlackRock Investment Management, LLC | 163 | $1,000 | 0.00% |
MORGAN STANLEY | 12,500 | $100,000 | 0.00% |